Obese Population Indonesia Market size: Ken Research

Indonesia healthcare market has shown a positive incline during 2012-2017 but with respect to the expanding population of Indonesia, the market is still underserved especially in the underdeveloped and rural areas as of 2017. People across Indonesia are facing several health care issues due to sedentary lifestyle and fast food consumption habits, such as obesity,… Continue reading Obese Population Indonesia Market size: Ken Research

Clinical Laboratory Market Future Trends Indonesia

https://www.kenresearch.com/blog/wp-content/uploads/2018/02/clinical-laboratory.jpg

Implementation of JKN (National Health Insurance System) by the government, expansion of major laboratory chains, improving margins and technology advancements were the key factors driving growth in Indonesia clinical laboratory Market.

Indonesia healthcare market has shown a positive incline during 2012-2017 but with respect to the expanding population of Indonesia, the market is still underserved especially in the underdeveloped and rural areas as of 2017.

Greater Universal Health Coverage has increased accessibility to healthcare services, leading to a rising number of the population seeking treatment and thereby increasing laboratory testing. The UHC scheme has increased the demand for basic and specialized testing. Since public clinical labs are not equipped with the technology for specialized testing, such tests have been outsourced to private independent labora

Trends in Indonesia Clinical Laboratory Market

https://www.kenresearch.com/blog/wp-content/uploads/2018/02/clinical-laboratory.jpg

Indonesia clinical laboratory market segment (by type of clinical laboratory, by type of private independent laboratory, by type of customer, by payer, by type of test and by region), competitive landscape of major players in Indonesia clinical laboratory market, and covering company profile of major clinical labs including Prodia, Kimia Farma Diagnostika, Pramita, Cito, BioMedika and Parahita. The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions. 

  • The healthcare market in Indonesia was majorly impacted by the implementation of JKN (Indonesian National Health Insurance) as the demand for affordable/primary healthcare services, laboratory services, and gener

Indonesia Pharmaceutical Market is expected to Reach USD 10.3 Billion by 2022: Ken Research

Indonesia pharmaceutical market segment (by therapeutic segment, by domestic & international players, by generic & patented drug, by OTC & prescription drugs, by domestic sales & exports and by region), competitive landscape of major players in the Indonesia pharmaceutical market covering company profile of PT Kalbe Farma, PT Sanbe Farma, PT SOHO Global Health, PT… Continue reading Indonesia Pharmaceutical Market is expected to Reach USD 10.3 Billion by 2022: Ken Research

Indonesia Pharmaceutical Market Outlook to 2022: Ken Research

https://www.kenresearch.com/blog/wp-content/uploads/2018/02/Indonesia-Dietary-Vitamin-Supplements-Market.jpeg

Indonesia Pharmaceutical Market Outlook to 2022 – By Therapeutic Segment (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology), By Domestic and International Players, By Generic and Patent Drugs, By OTC & Prescription Drugs, By Region” provides information on market size for Indonesia Healthcare and pharmaceutical.

<img class="size-full wp-image-36677 aligncenter" src="http://www.kenresearch.com/blog/wp-content/uploads/2018/02/Indonesia-Pharmaceutical-Market-Ecosystem.jpg&quot; alt="Indonesia Pharmaceutical Market Ecosystem" width="620" srcset="https://www.kenresearch.com/blog/wp-content/uploads/2018/02/Indonesia-Pharmaceutical-Market-Ecosystem.jpg 2048w, https://www.kenresearch.com/blog/wp-content/uploads/201

Indonesia Healthcare Market has been driven by Increase in Foreign Direct Investment and favourable Government Initiatives: Ken Research

Implementation of JKN (National Health Insurance System) by the government, growing foreign investment in the private hospital sector, expansion of service and product portfolio by major private hospital chains and pharmaceutical companies were the key factors driving growth in Indonesia Healthcare Market. The Indonesia healthcare market has shown a positive incline during 2012-2017 but with… Continue reading Indonesia Healthcare Market has been driven by Increase in Foreign Direct Investment and favourable Government Initiatives: Ken Research

Indonesia Healthcare Market is expected to Reach USD 32.5 Billion by 2022: Ken Research

Indonesia Healthcare market segment by hospital, pharmaceutical, pharmacy retail, clinical laboratory and medical devices, hospital market segment (by public & private hospitals, by general & specialty hospitals and by region), pharmaceutical market segment (by therapeutic segment, by domestic & international players, by generic & patented drug, by OTC & prescription drugs, by domestic sales &… Continue reading Indonesia Healthcare Market is expected to Reach USD 32.5 Billion by 2022: Ken Research